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Abstract
 
Human membrane cofactor protein (CD46) protects host cells against complement attack and
 
may function as a receptor for pathogenic 
 
Neisseriae
 
. We assessed CD46 expression in the human
cervical cell line ME-180 after exposure to 
 
Neisseria gonorrhoeae
 
. Piliated but not nonpiliated
gonococci adhered to cells and produced up to an 80% reduction in CD46 surface expression
by 6 h that persisted for at least 24 h. This response required a minimum multiplicity of infection of
10 and was not prevented by antibodies to CD46. CD46 down-regulation was not attributable
to intracellular retention or a global or specific shutdown of mRNA or protein synthesis. Sub-
stantial quantities of CD46 were found in the supernatants, indicating a specific shedding of this
protein. Adherent gonococci lacking the pilus retraction protein PilT did not down-regulate
 
CD46 but de-repression of 
 
pilT
 
 expression restored CD46 down-regulation. After experimental
infection of human volunteers with a gonococcal variant incapable of inducing CD46 down-
regulation, variants of this strain were reisolated that exhibited CD46 down-regulation. Pilus-
mediated interactions of gonococci with human epithelial cells results in a pathogen-induced
manipulation of the host cell environment in which a membrane protein is removed from epithelial
cells by liberation into the surrounding milieu.
Key words: Type IV pilus • PilT • pilus retraction • PilE • protein shedding
 
Introduction
 
The regulators of complement activation, a family of
plasma and membrane proteins that protect the host from
complement attack, are frequently targeted by pathogenic
microorganisms (for review see reference 1). Membrane
cofactor protein (CD46) is a member of this family that is
expressed on nearly all human cells. CD46 regulates com-
plement activation by serving as a cofactor for the plasma
serine protease factor I to cleave and thereby inactivate C3b
and C4b deposited on the same surface on which CD46 is
expressed (for review see reference 2). CD46 has also been
identified as a cellular receptor for several human pathogens,
including some strains of the measles virus (MV; references
3, 4), 
 
Streptococcus pyogenes
 
 (5), human herpes virus 6 (6),
and the pathogenic 
 
Neisseriae 
 
(7).
The role of CD46 in microbial pathogenesis has been
most studied in the case of the MV. MV-induced signaling
responses through CD46 include enhanced IL-12 secretion
(8) and increased release of nitric oxide through modulation of
IFN 
 
 
 
/
 
 
 
 synthesis (9, 10). In addition, regions of the cyto-
plasmic tail of CD46 are involved in the MV-induced pro-
cesses of syncytia formation and down-regulation of CD46
(11–16). The inhibition of this interaction with CD46 pep-
tides or mAbs specific to CD46 results in a loss of viral infec-
tivity (17–20). However, usage of this receptor may come
at a price, as the resulting loss of CD46 renders MV-infected
cells more susceptible to complement attack (15, 21, 22).
Initial adherence of 
 
Neisseria gonorrhoeae 
 
to the human
mucosal epithelium is thought to require CD46 and is facili-
tated by a multifunctional filamentous appendage known as
the Type IV pilus (Tfp). In addition to host cell adhesion,
expression of this organelle is associated with bacterial auto-
agglutination, competency for DNA transformation, and a
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mode of surface translocation known as twitching motility
(for review see reference 23). These processes are reliant on
coordinate expression and presentation of the multiple pro-
tein constituents of the pilus. The pilus components PilE
and PilC, both of which exhibit variable expression, are
two major adhesins in pilus-mediated gonococcal attach-
ment to host cells. PilE, or pilin, is the major pilus subunit,
and comprises the bulk of the pilus fiber. 
 
pilE
 
 exhibits fre-
quent sequence variation which arises from RecA-depen-
dent gene conversion between the 
 
pilE
 
 expression locus
and one of several silent 
 
pilS
 
 loci (24–26). These pilin
structural alterations modulate many aspects of pilus biol-
ogy including antigenicity, pilus-mediated adhesion, and
tissue tropism (27–29). Changes in PilE are thought to
contribute to host receptor recognition either through di-
rect, high-affinity interactions with host cell receptors or by
acting as a “molecular scaffold” for other adhesion-promot-
ing pilus constituents (for review see reference 23).
The pilus-associated protein PilC has also been identified
as a major pilus-associated adhesin based on the failure of
PilC null mutants to adhere to epithelial cells and inhibi-
tion of pilus-mediated gonococcal attachment to epithelial
cells by purified PilC preparations (28, 30). This protein
has been localized to the outer membrane as well as to the
tip of the pilus fiber (30, 31) and is expressed from two loci
(
 
pilC1
 
 and 
 
pilC2
 
), both of which undergo high frequency
on/off phase variation (32, 33). In addition to its apparent
role in host cell receptor recognition, PilC modulates the
dynamics of pilus fiber assembly and is essential for full
competence for DNA transformation (32–35).
Evidence for the role of CD46 as a pilus receptor in-
cludes binding of purified pili to CD46 in an overlay assay,
inhibition of gonococcal adherence by mAbs to CD46, and
adherence of piliated (P
 
 
 
) 
 
N. gonorrhoeae
 
 to CD46 transfec-
tants of otherwise nonpermissive cells (7). However, the
finding of an inverse correlation between CD46 expression
and adherence levels of P
 
 
 
 
 
N. gonorrhoeae 
 
to various epithe-
lial cell lines challenged the perception of CD46 as a classi-
cal receptor for 
 
N. gonorrhoeae
 
 (36). Other studies indicate a
 
potential role for CD46 in 
 
N. gonorrhoeae
 
 pathogenesis, es-
pecially an involvement of CD46 in intracellular signaling
associated with gonococcal attachment. These analyses in-
clude the induction of a CD46-dependent calcium flux
upon incubation of ME-180 cells with purified 
 
N. gonor-
rhoeae
 
 pili (37) and phosphorylation of Tyr 354 in the cyto-
plasmic tail of CD46 by the src kinase c-Yes after adher-
ence of P
 
 
 
 bacteria to A431 human endocervical cells (38).
Additionally, Chinese hamster ovary cells expressing tail
deletion constructs of CD46 did not support bacterial ad-
hesion (39), indicating that the CD46 cytoplasmic tail plays
a role in promoting adhesion.
Other responses of the host cell to pilus-mediated adher-
ence of the pathogenic 
 
Neisseriae 
 
have been described previ-
ously, including cytotoxicity for human cells (40, 41), in-
creased lysosome exocytosis (42), and cortical actin plaque
formation (43). The latter process is enhanced by expression
of the inner membrane protein PilT of 
 
N. gonorrhoeae
 
, an
ATPase thought to mediate retraction of the Tfp (44). PilT
is dispensable for pilus biogenesis and pilus-mediated adhe-
sion to cultured epithelial cells but is essential to DNA up-
take and twitching motility (45). The role of PilT in pilus
retraction and its contributions to cortical actin plaque for-
mation have sparked speculation that the tensile forces ex-
erted on the host cell membrane by retractile pili of adherent
 
N. gonorrhoeae
 
 activate mechanosensory signaling pathways
in the host cell to enhance gonococcal infectivity (43).
The putative role of CD46 as a cellular receptor for pi-
lus-associated adhesins (28, 30) in conjunction with the dy-
namic nature of pilus-mediated gonococcal adherence to
host epithelial cells (for review see reference 23) led us to
explore the effects of pilus-mediated adherence on CD46
expression and function. Here, we describe the down-reg-
ulation of CD46 in cultured human epithelial cells after ex-
posure to gonococci expressing retractile pili. The data are
consistent with a cellular response to pilus-mediated gono-
coccal attachment that is reliant on PilT-dependent pro-
cesses. In addition, after inoculation of male volunteers
with a non–down-regulating variant of 
 
N. gonorrhoeae
 
,
 
Table I.
 
Strains and Variants of Neisseria gonorrhoeae Used in This Study
 
Strain/variant Parent strain Piliation
 
a
 
Relevant characteristics Ref.
N401 (
 
recA6(kan)
 
)
 
b
 
N400
 
 
 
wild-type pilus expression 45
MW24 (PilE
 
ind
 
) N401
 
 
 
lacks major pilus subunit 35
GT104 (PilT
 
ind
 
) N401
 
 
 
nonretractile pili
 
c
 
45
GU5 (
 
pilU
 
::Tn
 
erm
 
5) N400
 
 
 
hyperautoagglutinative 54
GV2 (PilV::
 
kan
 
) N400
 
 
 
poorly adherent 55
P1 FA1090
 
 
 
inoculum for male volunteers
 
d
 
P3, P6, P7, P11, P17 FA1090
 
 
 
isolated from infected male volunteers
 
d
a
 
As determined by colony morphology.
 
b
 
recA6
 
 is an IPTG-inducible allele of 
 
recA
 
.  In the absence of induction, recA is not expressed, minimizing antigenic variation.
 
c
 
PilT expression can be de-repressed with IPTG, restoring pilus retraction.
 
d
 
Unpublished data.T
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gonococcal pilin variants of this strain were isolated that
exhibited CD46 down-regulation. We hypothesize that
the down-regulation of CD46 represents a pathogen-
induced alteration in the host cell designed to promote
gonococcal infectivity.
 
Materials and Methods
 
Cell Lines and Bacterial Strains. 
 
The cell lines ME-180, SiHa,
FaDu, HeLa, Hep-2, Chang, and T84 (HTB-33, HTB-35,
HTB-43, CCL-2, CCL-23, CCL-20.3, and CCL-248, respec-
tively) were obtained from American Type Culture Collection.
ME-180 cervical epithelial cells were maintained in McCoy’s 5A
medium supplemented with 10% heat-inactivated FCS. Chang
cells were maintained in Medium 199 supplemented with 10%
FCS. Other cell lines were maintained in DMEM 
 
 
 
 10% FCS.
All bacteria were grown for 18–20 h on GC agar supple-
mented with Isovitalex (Becton Dickinson) at 37
 
 
 
C in a 5% CO
 
2
 
atmosphere. Piliation state and Opa expression of each population
was determined by observation of colony morphology using an
inverted stereomicroscope with a diascopic base. Colonies of P
 
 
 
bacteria were identified by their dense, domed colonies as de-
scribed by Swanson et al. (46). 
 
N. gonorrhoeae
 
 strains used in this
work are summarized in Table I. N401 and its derivatives lacking
the pilus constituents PilE, PilT, PilV, and PilU have been de-
scribed previously as indicated in Table I. Based on colony mor-
phology, cultures were judged to be 
 
 
 
95% homogeneous in
their piliation state before use. Where indicated, de-repression of
PilT expression was achieved using isopropyl-
 
 
 
-
 
d
 
-thiogalactopy-
ranoside (IPTG; Sigma-Aldrich).
Pilin variants selected by in vivo passage of 
 
N. gonorrhoeae
 
 strain
FA1090 through human hosts were isolated from male subjects,
who were infected experimentally with this strain, using the pro-
cedures described by Cohen et al. (47) and Jerse et al. (48). The
inoculum was a P
 
 
 
 variant of strain FA1090 used in previous
analyses (48, 49); the pilin expressed by this variant was arbitrarily
designated P1. Gonococci cultured from urine or urethral swab
specimens from infected subjects show shifts in the preponder-
ance of variants expressing new pilin sequences (unpublished
data). The colony variants designated P3, P6, P7, P11, and P17,
each of which expresses pilin protein (PilE) with a different pri-
mary sequence, are representative of some of the pilin variants
that predominated in experimentally infected subjects at different
times after inoculation.
To minimize variation, in vivo-derived variants of strain
FA1090 were cultured directly from frozen stock and P
 
 
 
 bacteria
were selected based on colony morphology, recultured, and
pooled. Pooled bacteria were used to prepare a frozen stock from
which bacteria were cultured for each independent experiment
without additional passage. Before each experiment, plates were
examined to determine piliation state and the predominant colony
morphology for each variant (
 
 
 
65%) was indicative of a P
 
 
 
 state.
In some experiments, bacteria were heat killed by incubation
for 5 min at 95
 
 
 
C before addition to cultured cells or were treated
with chloramphenicol at a concentration of 200 
 
 
 
g/ml 30 min
before and during the incubation with cultured cells.
 
Immunostaining of Cell Surface Proteins for FACS
 
®
 
 Analysis.
 
ME-180 cells were seeded in 6-well tissue culture–treated plates
at 1.5 
 
 
 
 10
 
5
 
 cells/well and incubated overnight. Gonococci, sus-
pended in fresh, serum-free cell culture medium, were added to
each well at the appropriate multiplicity of infection (MOI; based
on OD
 
600
 
 where OD
 
600
 
 of 1.0 
 
 
 
 10
 
9
 
 bacteria/ml). Cells were in-
 
cubated at 37
 
 
 
C in a 5% CO
 
2
 
 atmosphere. At indicated time
points, monolayers were washed three times with McCoy’s 5A
medium, and trypsin was added for 1 min at RT. The cells were
scraped into 350 
 
 
 
l FACS
 
®
 
 buffer (1% FCS in PBS) followed by
a 5-min centrifugation. Pelleted cells were resuspended in FACS
 
®
 
buffer containing 25 
 
 
 
g/ml TRA-2-10, a mAb specific to the
NH
 
2
 
-terminal complement control protein repeat of CD46 (50),
followed by a 15–30 min incubation at 4
 
 
 
C. Next, the cells were
washed twice in cold FACS
 
®
 
 buffer and resuspended in a 1:100
dilution of FITC-conjugated goat anti–mouse antibody (Sigma-
Aldrich). After 15–30 min incubation at 4
 
 
 
C, cells were washed
twice and resuspended in FACS
 
®
 
 buffer with 0.5% paraformalde-
hyde. Other primary antibodies similarly used in this work in-
cluded anti–decay-accelerating factor (DAF; Accurate Chemical
and Scientific Corporation), anti–E-cadherin (Becton-Dickin-
son), and anti-HLA (BD Biosciences).
 
Western Immunoblot and ELISA. 
 
ME-180 cells were infected
with N401 (P
 
 
 
), MW24 (nonpiliated [P
 
 
 
]), or medium alone as
described for immunostaining. At each time point, cells were har-
vested, counted, and washed in PBS before resuspension in lysis
buffer (1% Nonidet P-40 and 0.05% SDS in PBS) with Complete
Protease Inhibitor Cocktail (Roche) at a concentration of 2 
 
 
 
10
 
7
 
 cells/ml (51). After a 15–20 min incubation on ice, the solu-
bilized-cell preparations were centrifuged at 12,000 
 
g
 
 for 10 min.
The lysates were electrophoresed on 10% SDS-PAGE and trans-
ferred to a nitrocellulose membrane using an XCell II Blot Mod-
ule (Novex) as per the manufacturer’s recommendations. Mem-
branes were incubated in Tris buffered saline with 0.05% Tween
20 containing 2% nonfat dry milk for 1 h at 37
 
 
 
C, washed, and
immunoblotted using rabbit polyclonal anti-CD46 antiserum
(1:7,000) followed by HRP-conjugated donkey anti–rabbit IgG
(1:7,000). Blots were washed in Tris buffered saline with 0.05%
Tween 20 before being developed with reagents (Supersignal
West Pico Luminol; Pierce Chemical Co.). To verify equal load-
ing, blots were stripped using the Western Blot recycling kit (Re-
Blot Plus; Chemicon International), probed with a goat anti–
glyceraldehyde-3-phosphate dehydrogenase (1:1,000; Chemicon
International) followed by an HRP-conjugated donkey anti–goat
secondary antibody (1:15,000; Jackson ImmunoResearch Labora-
tories). CD46 in cell lysates was also quantified by ELISA as de-
scribed by Liszewski et al. (51).
 
Preparation of Cell Culture Supernatants. 
 
10
 
6
 
 ME-180 cells
were incubated with N401 (MOI 
 
  
 
1,000), MW4 (MOI 
 
 
 
1,000), or medium alone for 5.5 h. Supernatants (12 ml each)
were collected and monolayers were washed once with 12 ml of
medium. The wash was pooled with the supernatant and centri-
fuged at 30,000 
 
g
 
 for 1 h at 4
 
 
 
C. These supernatants were trans-
ferred to a centrifugal filter device (Centricon-Plus-20; Millipore)
and concentrated to 1.5 ml as per the manufacturer’s instructions.
Corresponding cell monolayers were lysed in 1.5 ml lysis buffer
and both lysates and concentrated supernatants were analyzed by
Western immunoblot and ELISA.
 
RT-PCR. 
 
RT-PCR analysis was performed as described by
Wang et al. (52).
 
Adherence Assays. 
 
Adherence assays were performed as de-
scribed previously (36). In brief, bacteria were fluorescently la-
beled by incubation with carboxyfluorescein diacetate succini-
midyl ester (Molecular Probes) for 20 min at RT, and labeling of
each bacterial population was assessed by FACS
 
®
 
 to ensure equiv-
alent staining of all populations being tested. Bacteria were
washed twice with PBS, resuspended to OD
 
600
 
 
 
  
 
1.0, and added
to 6-well plates containing 70–80% confluent monolayers of the
cultured epithelial cell lines to achieve an MOI of 100. After aT
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4-h incubation at 37 C with 5% CO2, cells were washed,
trypsinized for 1 min, and resuspended in 300  l FACS® buffer.
Flow cytometry was performed as described in the next para-
graph. Adherence was also monitored using an inverted light mi-
croscope and fluorescence microscopy.
Flow Cytometry.  Flow cytometry was performed using a
FACSCalibur™ (Becton Dickinson) using forward and side scatter
thresholds optimized for ME-180 cells. Fluorescence was ac-
quired on a four-decade log scale wherein instrument settings
were adjusted such that fluorescence of unstained cells fell within
the first decade. Changes in fluorescence intensity resulting from
binding of fluorescently labeled antibodies or bacteria to epithelial
cells are expressed as mean fluorescence or geometric mean, re-
spectively, that was calculated from histograms plotting fluores-
cence on an arbitrary linearized scale versus number of events. A
minimum of 10,000 events were collected per sample and no gat-
ing was applied.
Immunofluorescent Microscopy.  ME-180 cells were cultured
overnight in 6-well chambered slides and incubated with N. gonor-
rhoeae at an MOI of 100 for 4 h at 37 C in 5% CO2. After three to
five washes (PBS   1% FCS), gonococci adhering to the mono-
layer were stained with Syva Microtrak Reagent A (Trinity Bio-
tech) or with a polyclonal antiserum against a major outer mem-
brane protein of N. gonorrhoeae (1:100; Biodesign International)
followed by a FITC-conjugated anti–rabbit IgG (Sigma-Aldrich).
Next, cells were washed twice and fixed with PBS containing 2%
paraformaldehyde and 0.5% glutaraldehyde. After the chambers
were removed, coverslips were mounted using a 50% solution of
glycerol in PBS. Cells were visualized at a magnification of 1,000
using a fluorescent microscope (model E400; Nikon) equipped
with MagnaFire digital camera and imaging software.
Results
Adherence of P  N. gonorrhoeae to ME-180 Cells Down-reg-
ulates CD46.  To determine if adherence of P  gono-
cocci to epithelial cells results in modulation of CD46 ex-
pression, ME-180 cells were incubated with N401 (P ),
MW24 (P ), or medium alone for up to 24 h. FACS® and
Western immunoblots demonstrated that incubation of
ME-180 cells with P  N. gonorrhoeae, but not P  N. gonor-
rhoeae, led to a reduction in CD46 expression (Fig. 1).
These results were confirmed by ELISA of CD46 in whole
cell lysates (not depicted). Experiments wherein CD46 lev-
els were examined by FACS® at 30-min intervals up to 8 h
after addition of P  N. gonorrhoeae established that the de-
crease in CD46 was detectable by 3.5 h and maximal by 6 h
(unpublished data). A similar decline in CD46 expression
to that seen with an MOI of 1,000 was induced by an MOI
of 100, whereas an MOI of 10 induced a more modest de-
crease in CD46 and an MOI of 1 did not influence CD46
expression (Fig. 2). In addition, incubation of ME-180 cells
with heat-killed or chloramphenicol-treated N. gonorrhoeae
did not lead to CD46 down-regulation (not depicted).
Figure 1. Adherence of P  N.
gonorrhoeae to ME-180 cells leads
to down-regulation of CD46.
ME-180 cells were incubated with
N401 (P ) N. gonorrhoeae (MOI  
1,000), MW24 (P ) N. gonorrhoeae
(MOI   1,000), or medium alone
for up to 24 h. CD46 levels were
assessed at time points indicated by FACS® (A) or Western immunoblot (B). The
Western immunoblot shows the typical SDS-PAGE electrophoretic pattern of
CD46 expressed by ME-180 cells, consisting predominantly of the more heavily
O-glycosylated upper band isoforms (BC1 and BC2) and smaller amounts of the
lower band isoforms (C1 and C2). (A and B) CD46 levels in uninfected cells are similar
to P  infected controls and have been omitted for clarity. In A and in subsequent
figures, controls wherein primary antibody was omitted are represented as a peak
in the first decade of the four-decade log scale. (B) “Control” lane contains cell lysates
of CHO cells transfected with BC2 or C2 isoforms of CD46.
Figure 2. CD46 down-regu-
lation is dependent on bacterial
adherence. (A) FACS® was used
to evaluate CD46 expression on
ME-180 cells that were incubated
with N401 (P ) N. gonorrhoeae at
the MOIs noted for 0 or 24 h.
Bacterial adherence at each MOI
was also assessed at 4 h after infec-
tion  using immunofluorescent
microscopy at a magnification of
1,000 and by FACS® (B). Images
in B are representative of one of
at least ten fields examined in
each of three similar experiments.
Values in B indicate mean   SD
of triplicate samples from one of
three independent experiments.T
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Six additional human epithelial cell lines (T84, HeLa,
Hep-2, FaDu, SiHa, and Chang) were investigated for
CD46 down-regulation (unpublished data). At an MOI of
1,000, this phenomenon was observed in T84 and intermit-
tently in HeLa, but the effect was not seen in the remaining
four cell lines despite similar or greater levels of CD46 ex-
pression. Consistent with previous papers, gonococcal ad-
herence to all non–down-regulating cell lines were signifi-
cantly lower than those observed with ME180 and T84 (36,
39). Due to the high levels of bacterial adherence and CD46
down-regulation observed in ME-180, this cell line was
subsequently used to further investigate the bacterial and
host cell interactions involved in CD46 down-regulation.
Antibodies to CD46 Do Not Block CD46 Down-regula-
tion.  Because N. gonorrhoeae adherence and pilus-induced
Ca2  flux are inhibited by treatment with mAbs to CD46 (7,
37), we asked if N. gonorrhoeae–induced CD46 down-regula-
tion could be similarly blocked. ME-180 cells were incu-
bated with the CD46-specific mAbs GB24 and TRA-2–10
(50) for 30 min before addition of N401 (P ) N. gonorrhoeae,
MW24 (P )  N. gonorrhoeae, or medium alone. Antibody
cross-linking alone did not result in modulation of CD46
expression and these mAbs did not inhibit CD46 down-reg-
ulation resulting from adherence of P   N. gonorrhoeae to
ME-180 cells (Fig. 3 A). Furthermore, microscopic exami-
nation of N. gonorrhoeae adherence in the presence of mAbs
to CD46 (Fig. 3 B) indicated similar levels of adherence in
the presence of these and other mAbs to CD46, including
122-2, E4.3, and J4-48 (Research Diagnostics Inc.) as well as
a rabbit polyclonal antiserum (not depicted). These results
suggest that the down-regulation of CD46 may not require
direct contact between pili and the ectodomain of CD46.
Mechanism of CD46 Down-regulation.  Studies of CD46
down-regulation in response to MV infection have indi-
cated that surface expression of CD46 declines but total cel-
lular levels of CD46 remain constant, suggesting internal-
ization without intracellular degradation (13). However, in
the case of N. gonorrhoeae–induced CD46 down-regulation,
a comparison of changes in CD46 expression on the cell
surface (Fig. 1 A) and in the whole cell lysates (Fig. 1 B) es-
tablished that CD46 is lost not only from the cell surface
but also is not detectable intracellularly. However, Western
immunoblot analysis of treated cell supernatants revealed
substantial quantities of CD46 with the expected molecular
weight in the supernatants of cells infected with P  bacteria
(Fig. 4). Quantitation by ELISA of CD46 in cell lysates and
the corresponding concentrated cell supernatants indicated
that 25–50% of the CD46 lost from infected cells was re-
covered in the supernatants. In addition, RT-PCR analyses
established that the loss of CD46 is not accompanied by de-
creased quantities of CD46 mRNA (not depicted).
We also addressed the possibility that CD46 down-regu-
lation was due to a more global loss of membrane constit-
uents. Surface expression of DAF (CD55), HLA, and
E-cadherin was assessed by FACS® under conditions that
induced CD46 down-regulation (Fig. 5). DAF, a comple-
ment regulatory protein functionally and structurally re-
lated to CD46 (for review see reference 53), showed mod-
est down-regulation in response to P   N. gonorrhoeae
adherence. However, HLA expression remained constant
whereas the cell adhesion molecule E-cadherin was up-
regulated. These data indicate that the loss of CD46 is not a
consequence of a generalized reduction in expression or
surface presentation of membrane proteins. In addition, the
coordinate down-regulation of CD46 and of the structur-
ally and functionally related DAF protein may be related to
a cooperative interaction between these proteins (54).
PilT Is Necessary for Induction of CD46 Down-regulation.
Given the dependence of CD46 down-regulation on pilus-
mediated adherence, we assessed adherence levels and CD46
Figure 3. Antibodies to CD46 do not inhibit CD46 down-regulation
or adherence of P  N. gonorrhoeae to CD46. (A) ME-180 cells were incu-
bated for 30 min with the CD46-specific mAbs TRA-2-10 and GB24
(100  g/ml each), which recognize epitopes in the NH2-terminal and
COOH-terminal repeating modules of the ectodomain, respectively (50).
P  N. gonorrhoeae, P  N. gonorrhoeae, or medium alone was added. Next,
cells were analyzed for CD46 expression by FACS® at time points indicated.
Values represent mean   SD of triplicate samples from one of three similar
experiments. (B) ME-180 cells were incubated for 30 min with anti-
CD46 mAbs GB24 and TRA-2-10 at the concentrations shown. Cells
were incubated with N401 (P ) N. gonorrhoeae at an MOI of 100 for 4 h
and washed; adherent bacteria were detected by immunofluorescent
staining at a magnification of 400. Images are representative of at least 10
fields from one of three separate experiments.
Figure 4. CD46 is found in supernatants after down-regulation. Cell
culture supernatants of ME-180 cells were harvested and concentrated
eightfold (1.5 ml final volume) after infection with N401 (P ), MW4
(P ), or medium alone (Con). These supernatants and corresponding cell
monolayers (solubilized in 1.5 ml lysis buffer) were analyzed for CD46 by
Western immunoblot. Lane one contains solubilized preparation of Hep-2
epithelial cells. Results are representative of three independent experiments.T
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regulatory capabilities of mutants (Table I) lacking specific
components of this organelle. The PilTind mutant (which
does not express the pilus retraction protein PilT in the ab-
sence of the inducer IPTG) was hyperadherent in compari-
son to N401 (Fig. 6 A) and did not result in CD46 down-
regulation (Fig. 6 B). De-repression of PilT restored the
capacity to down-regulate CD46 in ME-180 cells (Fig. 7),
indicating that PilT was essential to the induction of CD46
down-regulation. Down-regulation of CD46 after induction
of PilT expression in the PilTind mutant occurred several
hours later than that seen with N401, probably reflecting ei-
ther delayed or reduced expression of PilT in this mutant.
Interruption of pilT expression is known to also elimi-
nate expression of the downstream gene pilU, which en-
codes a protein that contributes to pilus-mediated adher-
ence and autoaggregation (55). Therefore, it was necessary
to evaluate CD46 down-regulation by PilU   N. gonor-
rhoeae to ensure that the loss of CD46 down-regulation in
the PilTind mutant was not due to disruption of PilU ex-
pression. The PilU  mutant, which expresses retractile pili
(55), was also hyperadherent (Fig. 6 A) and induced CD46
down-regulation similar to that seen with the control strain
N401 (Fig. 6 B), establishing that disruption of pilU gene
expression does not account for loss of CD46 down-regu-
lation observed for PilT  N. gonorrhoeae.
Together, these results imply a correlation between ad-
herence, retractile Tfp, and CD46 down-regulation. Given
the role of the pilus-associated protein and putative adhesin
PilC in promoting adherence (28, 30), we sought to exam-
ine a potential role for PilC in induction of CD46 down-
regulation. However, it was not possible to test mutants
expressing retractile Tfp in the absence of PilC as the re-
quirement for PilC in pilus biogenesis can only be sup-
pressed in a PilT null background (45). Alternatively, we
assessed a PilV null mutant that retains expression of retrac-
tile Tfp but adheres inefficiently due to a defect in presen-
tation or exposure of PilC (56). This mutant did not induce
CD46 down-regulation (Fig. 6 B). Based on these data, we
conclude that CD46 down-regulation is reliant on expres-
sion of PilT and proper presentation of PilC.
CD46 Down-regulation by In Vivo–derived Variants of N.
gonorrhoeae Strain FA1090.  To determine if induction of
CD46 down-regulation was induced by N. gonorrhoeae
strains other than N401, the in vivo–derived variants of N.
gonorrhoeae strain FA1090 (Table I) were tested for their
ability to adhere to and induce CD46 down-regulation in
ME-180 cells (Fig. 8). Variants P3, P6, P7, P11, and P17
were isolated from experimentally infected male volunteers
at various times after urethral inoculation with the variant
designated P1 and are representative of variants arising in
vivo expressing new pilin sequences (unpublished data).
Microscopic examination and FACS®-based adherence as-
says revealed low levels of adherence for variants P1, P3,
and P11 and high levels of adherence for variants P6, P7,
and P17 when compared with adherence of strain N401
(Fig. 8 A). Incubation of ME-180 cells with those variants
that adhered well to ME-180 resulted in CD46 down-reg-
Figure 5. Adherence of P  N. gonorrhoeae also alters expression of DAF
and E-cadherin but not HLA. ME-180 cells were incubated with N401
(P ) N. gonorrhoeae (MOI   1,000), MW24 (P ) N. gonorrhoeae (MOI  
1,000), or medium alone. Surface expression of CD46, DAF, HLA, and
E-cadherin were assessed by FACS®. Profiles for uninfected samples were
identical to those for P  N. gonorrhoeae–infected samples and are not shown
for clarity. Results are representative of three independent experiments.
Figure 6. CD46 down-regulation by pilus mutants of strain N401. N401
(P ) and its mutants (Table I), MW4 (P ), GT104 (PilTind), GV2 (PilV ), or
GU5 (PilU ), were analyzed for adherence (A) and CD46 down-regulation
(B). Adherence was assessed by FACS® at 4 h after infection (MOI   100)
whereas CD46 levels were analyzed by FACS® after incubation of bacteria
with ME-180 cells for 6 and 24 h (MOI   100). Results at 6 h (not depicted)
were similar to those at 24 h. Data are expressed as mean   SD of triplicate
samples from one of three independent experiments.T
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ulation similar to that induced by N401, whereas the three
remaining variants (all of which showed lower levels of ad-
herence) did not induce CD46 down-regulation (Fig. 8 B).
These results are consistent with the requirement for bacte-
rial adherence for CD46 down-regulation and indicate that
this response is not induced solely by N401 and its deriva-
tives. Although not all of the in vivo–derived variants in-
duced CD46 down-regulation, down-regulation occurred
with three of the five variants that were reisolated from hu-
man volunteers after experimental inoculation with the
non–down-regulating variant P1. In addition, one of the
non–down-regulating variants (P3) was only isolated early
in the experimental infection. Attachment of three of the
four variants that persisted late in infection (P6, P7, P11,
and P17), led to CD46 down-regulation. Together, these
results suggest that those variants favored by in vivo selec-
tive pressures in the human male urethra are capable of
CD46 down-regulation.
Discussion
We describe the down-regulation of CD46 after pilus-
mediated adherence of N. gonorrhoeae to ME-180 cells.
This effect was reliant on bacterial adherence, requiring an
MOI of 10 or greater, was not inhibited by mAbs to
CD46, and was accompanied by the accumulation of
CD46 in the supernatant. The down-regulatory response
was induced by the laboratory strain N401 as well as by P ,
in vivo–derived variants of strain FA1090 and was inhibited
by null mutations in the twitching motility protein PilT.
Although the mechanism underlying this reduction in
CD46 expression remains under investigation, we have ad-
dressed several processes that could account for this down-
regulation. In ME-180 cells challenged with P  gonococci,
both surface presentation and total cellular content of
CD46 were reduced with similar kinetics, indicating that
CD46 is not internalized and maintained as such within the
cell. In addition, we conclude that after incubation with P 
gonococci, CD46 down-regulation was not due to a global
reduction in expression or surface presentation of mem-
brane proteins as was illustrated by the unchanged expres-
sion of HLA and up-regulation of E-cadherin. In addition,
RT-PCR demonstrated that CD46 down-regulation does
not coincide with a specific decrease in CD46 mRNA.
However, substantial quantities of CD46 (at least 25–50%
of that lost from the surface) were found in the media of
infected cells. The molecular weight of CD46 in the super-
natant is not detectably altered, arguing against a pro-
teolytic cleavage event. Therefore, we currently favor and
are pursuing the hypothesis that CD46 is lost from the cell
surface into the supernatant via a shedding mechanism.
The down-regulation of CD46 resulting from pilus-
mediated adhesion requires expression of the twitching
motility protein PilT and is manifest 3.5–6 h after addition
of bacteria. Certain other processes related to pilus-medi-
ated adherence of N. gonorrhoeae show similar delayed ki-
netics and dependence on expression of PilT. For example,
the PilT-dependent formation of cortical actin plaques be-
gins within minutes of bacterial adhesion but is not maxi-
Figure 7. PilT is necessary to induce CD46
down-regulation. ME-180 cells were incubated
with the PilTind mutant in the presence or absence
of IPTG (for de-repression of PilT expression).
CD46 expression was examined by FACS® at 0,
6, and 24 h after infection. Results are repre-
sentative of three similar experiments.
Figure 8. Adherence levels and CD46 down-regulation by clinically
relevant variants of N. gonorrhoeae strain FA1090. ME-180 cells were incu-
bated with six variants of N. gonorrhoeae strain FA1090, strains N401 (P )
or MW24 (P ), or medium alone (Con). Variants P3, P6, P7, P11, and
P17 (Table I) were isolated from male volunteers after inoculation with
the variant designated P1. FACS® analysis of adherence (4 h after infection;
MOI   100) (A) and CD46 expression (6 h after infection; MOI  
1,000) (B). CD46 levels after a 24-h incubation were similar to those after
a 6-h incubation (not depicted). Results are expressed as mean   SD of
triplicate samples from one of three independent experiments. Those
variants that were detectable at the time urethritis developed (day 3 or 4)
are indicated with a positive sign whereas the inoculating strain (P1) and
the variant (P3) that were detected early in infection (day 1) but not at the
time of urethritis are indicated with a minus sign. Characterization of Opa
expression of these variants revealed no correlation between expression of
a specific Opa protein and the ability of a variant to induce CD46 down-
regulation (not depicted), indicating that the observed differences in
adherence and CD46 down-regulation are most likely attributable to
variations in their pilin sequences.T
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mal until 4–6 h after infection (43, 57). In addition, the
progression from pilus-mediated adherence to intimate
association by Neisseria meningitidis (58), which occurs in
conjunction with a reduction in piliation and by tight jux-
taposition of the bacterial and host cell membranes (for re-
view see reference 23), is also PilT dependent and occurs
between 4 and 9 h after infection. Due to variation in cell
type and bacterial strain used for these studies, conclusions
can only be cautiously drawn on the interrelatedness of
CD46 down-regulation, cortical actin plaque formation,
progression to intimate association, and other cellular re-
sponses for attachment of N. gonorrhoeae. Nevertheless, an
attractive explanation for the role of PilT in inducing all
three responses could involve tensile forces exerted by re-
tractile pili inducing mechanosensory signaling responses in
mammalian cells, as proposed by Merz and So (23).
Although MV and N. gonorrhoeae infection induce a sim-
ilar modulation of CD46 expression, there were some
notable differences regarding the microbial constituents
necessary to induce this response. Modulation of CD46 ex-
pression by MV requires a direct, protein–protein interac-
tion between the NH2-terminal region of CD46 and the
MV hemagglutinin (12, 59). Inhibition of this interaction
with mAbs to either protein prevents MV adherence as
well as the induction of CD46 down-regulation (17, 18,
15, 19, 20). In contrast, our data from three lines of experi-
mentation suggest that direct contact between CD46 and
N. gonorrhoeae pili may not be necessary in the induction of
N. gonorrhoeae–induced CD46 down-regulation or in adhe-
sion of N. gonorrhoeae to host cells. We first demonstrated
that preincubation of ME-180 cells with multiple mAbs to
CD46, including those that are known to inhibit MV ad-
herence (e.g., TRA-2-10; references 16–20) as well as
those that have been described to inhibit N. gonorrhoeae at-
tachment (e.g., GB24; reference 7), did not result in inhibi-
tion of N. gonorrhoeae adherence or the resulting down-reg-
ulation of CD46 (Fig. 3). Second, studies using ELISA and
an overlay assay showed no direct interaction between pu-
rified pili and CD46 (unpublished data). Finally, upon ex-
amination of gonococcal adhesion to multiple cell lines,
our data support the previously observed inverse correla-
tion between CD46 expression and bacterial adhesion (36).
The cell lines that supported high levels of N. gonorrhoeae
adhesion (despite comparatively low levels of CD46 ex-
pression) also exhibited N. gonorrhoeae–induced down-reg-
ulation of CD46. As these data collectively suggest that N.
gonorrhoeae adherence does not require a direct interaction
between the N. gonorrhoeae pilus and CD46, we speculate
that N. gonorrhoeae adherence and the induction of CD46
down-regulation may be reliant on interactions of bacterial
adhesins with other as yet unidentified cell surface mole-
cules. These molecules may not be present in cell lines that
display neither high levels of gonococcal adhesion nor N.
gonorrhoeae–induced CD46 down-regulation.
The role of PilT in pilus retraction coupled with the ne-
cessity for PilT expression in the induction of CD46
down-regulation suggests that pilus retraction contributes
to the induction of CD46 down-regulation. If an active
bacterial response such as pilus retraction is necessary for
CD46 down-regulation, activation of a cellular receptor
through static binding of a bacterial adhesin could be an in-
sufficient stimulus. Supporting evidence for this line of rea-
soning comes from the inability of the PilV  mutant to
elicit this response. Loss-of-function mutants in the minor
pilin subunit PilV retain retractile pili yet display reduced-
affinity interactions with ME-180 cells, a property attrib-
uted to a concomitant defect in presentation of the adhesin
PilC (56). The absence of CD46 down-regulation despite
normal retractile capability of the PilV  pilus, coupled with
the necessity of PilT in induction of this response, implies a
simultaneous requirement for high-affinity adhesion and
pilus retraction in the induction of CD46 down-regulation.
This implies that, in contrast to the interaction between
MV hemagglutinin and CD46, a static interaction between
gonococcal adhesins and host cell surface receptors is insuf-
ficient to induce CD46 down-regulation.
Several pilus-associated properties influencing Neisseria
adherence to human epithelial cells are affected by sequence
variation in pilE arising from natural antigenic variation (for
review see references 60, 61). Examination of pilE sequences
after passage of N. gonorrhoeae strain FA1090 through the hu-
man host indicates rapid shifts in predominant pilin sequence
(not observed upon in vitro passage), suggesting strong se-
lective pressures for specific attributes of the gonococcal pi-
lin (49). In this paper, induction of CD46 down-regulation
by variants of strain FA1090 that had been reisolated from
human hosts after inoculation with a non–down-regulating
strain (variant P1) point to selective pressures for gonococci
capable of modulating CD46 expression. Based on the de-
pendence of CD46 down-regulation on pilus expression (as
per experiments herein with pilus mutants of strain N401)
combined with analyses of the effects of antigenic variation
in PilE on in vivo selection and adherence to epithelial cells
(27–29), alterations in the pilE sequence likely account for
differences in CD46 modulatory capabilities of the in vivo–
derived variants. Future papers will assess these variations in
PilE as well as differences in PilT and PilC among the six
FA1090 variants used in this work.
Although it remains to be determined if the loss of
CD46 aids or hinders gonococcal pathogenesis, we propose
that this process favors bacterial virulence and requires
cross-talk between the pilus and CD46. The mechanism by
which CD46 is shed from the cell membrane will be one
focus of our investigations, as delineating this process may
be fundamental to increasing our understanding of this in-
teraction between a major human pathogen and CD46 of
host cells.
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